SANUWAVE Health (SNWV) Income from Continuing Operations (2010 - 2026)
SANUWAVE Health's (SNWV) quarterly Income from Continuing Operations came in at 3513000.0 in Q1 2026, down 168.58% year-on-year from 5122635.45 in Q1 2025, and down 146.9% on a QoQ basis from 7490000.0 in Q4 2025.
SANUWAVE Health (SNWV) Income from Continuing Operations (2010 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has 17 years of Income from Continuing Operations data on file, last reported at 3513000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 168.58% year-over-year to 3513000.0 in Q1 2026; TTM through Mar 2026 was 2584000.0, a 147.26% increase from a year earlier, with the FY2025 full-year figure at 11813000.0, up 135.71% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3513000.0, down from 7490000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for SNWV reached as high as 18235000.0 in Q4 2023 and fell as low as 23700000.0 in Q3 2023.
- Historically, Income from Continuing Operations has averaged 2560529.41 across 5 years, with a median of 1779000.0 in 2024.
- Across the five-year window, Income from Continuing Operations sank 1980.77% in 2023 and jumped 1565.75% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 5685000.0 in 2022, then surged by 420.76% to 18235000.0 in 2023, then tumbled by 102.8% to 511000.0 in 2024, then jumped by 1565.75% to 7490000.0 in 2025, then slumped by 146.9% to 3513000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 3513000.0 in Q1 2026, 7490000.0 in Q4 2025, and 892000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SANUWAVE Health | 18.65 Mn | 7.87 Mn | 7.43 Mn | -3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.51 Mn |
| Dec 31, 2025 | 7.49 Mn |
| Sep 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | -511,000.00 |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -1.78 Mn |
| Mar 31, 2024 | -4.56 Mn |
| Dec 31, 2023 | 18.24 Mn |
| Sep 30, 2023 | -23.70 Mn |
| Jun 30, 2023 | -7.26 Mn |
| Mar 31, 2023 | -13.08 Mn |
| Dec 31, 2022 | -5.69 Mn |
| Sep 30, 2022 | -1.14 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | -5.10 Mn |
| Dec 31, 2021 | 18.62 Mn |
| Sep 30, 2021 | -4.25 Mn |
| Jun 30, 2021 | -8.62 Mn |